Clinical epidemiological characteristics of nitrous oxide abusers: A single-center experience in a hospital in China

Brain Behav. 2021 Dec;11(12):e2416. doi: 10.1002/brb3.2416. Epub 2021 Nov 13.

Abstract

Purpose: This study investigated the clinical epidemiological characteristics of nitrous oxide (N2 O) abusers in a hospital in China, which have not been systematically reported.

Methods: The characteristics of patients abusing N2 O who were examined and treated at the Affiliated Hospital of Xuzhou Medical University from January 2017 to December 2020 were analyzed.

Results: A total of 61 patients (average age: 21.7 ± 3.2 years; 42 male and 19 female) were enrolled; 60.7% of the patients had an education level of high school or lower, and most (59.0%) had no stable occupation. The mean exposure time was 8.5 ± 7.7 months (range: 1-36 months). Only 52.5% of the abusers reported the physician of the relevant exposure history at the first time of visiting the doctor. The main clinical type was mixed (49.2%). The most common clinical manifestation was distal limb numbness (80.3%). The most frequent outcome was peripheral neuropathy (59%) and subacute combined degeneration (36%). Serum homocysteine level was elevated in 67.5% (27/40) of the patients, while 44.4% (20/45) showed reduced vitamin B12. Note that 61% (22/36) showed abnormal signals in the posterior or lateral funiculus of the spinal cord, and 97% (31/32) of the patients showed peripheral nerve damage by electromyography. In all cases, symptoms were alleviated after halting N2 O intake and receiving nutritional neurotherapy.

Conclusions: N2 O abuse can lead to nervous system damage, especially peripheral nerve and spinal cord damage. A full understanding of its clinical epidemiological characteristics is helpful for clinicians to make a timely and clear diagnosis.

Keywords: epidemiology; neuropathy; nitrous oxide; public health; subacute combined degeneration; vitamin B12.

MeSH terms

  • Adolescent
  • Adult
  • China / epidemiology
  • Female
  • Hospitals
  • Humans
  • Male
  • Nitrous Oxide* / adverse effects
  • Subacute Combined Degeneration* / chemically induced
  • Subacute Combined Degeneration* / drug therapy
  • Vitamin B 12 / therapeutic use
  • Young Adult

Substances

  • Nitrous Oxide
  • Vitamin B 12